Safety There was a slight trend in lower occurrence of fibrosis, with IRay subjects developing fibrosis in 13.6% after 12 months vs. 18.0% of the control group, but this did not achieve statistical significance ( P = 0.219).
← all excerpts
IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration.
1
—
—